Study Design. A retrospective database analysis. Objective. The aim of this study is to compare rates of postoperative dysphagia, length of stay, infection, and wound complications following short and long anterior cervical discectomy and fusion (ACDF) in patients who received local intraoperative steroids and those who did not. Summary of Background Data. Only one prior small institutional study has investigated the application of local steroids at the time of ACDF to decrease postoperative dysphagia. Methods. A large administrative database was utilized to compare rates of postoperative dysphagia, length of stay, and infectious complications within 90 days in patients who received local steroid following short (1-2 level) and long (3 or more level) ACDF and control groups who did not. Nonobtainable information within the database included type of steroid, application technique, outcome data, and incidence of miscoding and noncoding by physicians. Odds ratios (ORs), 95% confidence intervals (95% CIs) and P values were then calculated using SPSS. Results. The incidence of dysphagia was significantly lower (9.0% vs. 14.6%, P ¼ 0.005) in patients who received local steroid in the long ACDF group (n ¼ 322) than a control group who did not (n ¼ 45,432). This was not observed (P ¼ 0.198) in the short ACDF group who received steroid (n ¼ 1770) compared with a control group who did not (n ¼ 198,230). The mean difference in length of stay was 1 day less for patients who received local steroid in both the short and long ACDF groups (P < 0.0001). The combined rate of postoperative infection and wound complications was not significantly different between steroid and control groups (P ¼ 0.717).
A nterior cervical discectomy and fusion (ACDF) has become a widely accepted and reliable technique for the treatment of cervical spine pathology. Although generally regarded as safe, anterior cervical surgery is associated with multiple potential comorbidities such as dysphagia, airway compromise, vocal cord paresis and paralysis, and vascular injury. 1 Among the aforementioned complications, dysphagia is the most common postoperative patient complaint. 2, 3 Dysphagia following ACDF is highly variable, with reported rates of 1% up to 79%, 1, [4] [5] [6] [7] with the severity ranging from mild subjective discomfort to respiratory distress and life-threatening airway obstruction requiring emergent reintubation or tracheostomy. 5, [8] [9] [10] Despite the high clinical significance and morbidity associated this complication, much of the available literature has focused on identifying risk factors that help to predict postoperative dysphagia, 11, 12 with less literature dedicated to prevention and treatment. [12] [13] [14] [15] Current research investigating preventative measures has focused on the administration of systemic corticosteroids to reduce local edema and prevent the prevertebral soft tissue swelling following surgery that results in dysphagia. [16] [17] [18] The results of these clinical studies have produced conflicting results, with no clear consensus on the true efficacy of systemic perioperative steroids in reducing postoperative dysphagia following ACDF. 16, 17, 19 Furthermore, only one prior study has investigated the effect of local steroid application to reduce prevertebral soft tissue swelling and postoperative dysphagia. 20 Given the variable incidence of postoperative dysphagia following ACDF, it is likely that a large cohort must be sampled to sufficiently power an adequate analysis of the association of intraoperative local steroid application and postoperative dysphagia. Although using a large administrative database would afford a large sample size, it also comes with several limitations that must be acknowledged. These include a lack of specific clinical outcomes data, the possibility of noncoding or miscoding by physicians, use of drains at the time of surgery, and the unknown dosage and application technique of steroid at the time of surgery.
The purpose of the present study was to utilize a national database to evaluate the association of intraoperative local steroid administration with the reduction of postoperative dysphagia and length of stay following long and short ACDF as well as any association between the use of local steroid during ACDF with the development of postoperative infection. Our hypothesis was that the intraoperative local administration of steroids would be associated with decreased rates of postoperative dysphagia and length of stay in patients undergoing ACDF, without any associated increase in infection rates.
MATERIALS AND METHODS

Database
The PearlDiver Patient Records Database (www.pearldiverinc.com, Fort Wayne, IN), a for-fee insurance-based database of de-identified patient records, was utilized for this study. The database contains procedural volumes, patient demographics, and average charge information for patients with International Classification of Disease, Ninth Revision (ICD-9) diagnoses and procedures of Current Procedural Terminology (CPT) codes. The quality of the data available within the database is dependent on the accuracy with which these procedures are coded. Miscoding and noncoding by physicians are potential sources of error. Thus, there may be patients within the database who were treated with local steroids at the time of surgery and not coded as such, and thus included within the incorrect cohort. Unfortunately, these instances are not identifiable, but would be assumed to be negligible given the sample size of the study. All data are de-identified and anonymous, and were thus exempt from the Institutional Review Board approval. All data for the present study were derived from a Medicare database within PearlDiver, which contains over 100 million individual patient records from 2005 to 2012.
Study Group
Patients who underwent ACDF were queried in the database using the following CPT codes: 22554, 22551, 22585, and 63076 in addition to the ICD-9 procedure code 810.2. This group was then separated into short (one-two level) and long (three or more level) ACDF by using the ICD-9 codes 816.2 and 816.3, respectively. Patients who had local application of steroid at the time of surgery were then identified using ''J'' codes for corticosteroid preparations administered as a local injection, including J3300 (injection, triamcinolone acetonide, 1 mg), J3301 (injection, triamcinolone acetonide, 10 mg), J1020 (injection, methylprednisolone acetate, 20 mg), J1030 (injection, methylprednisolone acetate, 40 mg), J1040 (injection, methylprednisolone acetate, 80 mg). It is important to note that the aforementioned codes are specific to the local application of steroid, which excludes any intravenous use of these medications. As previously mentioned, miscoding intravenous steroid administration as local administration would be a source of error within this study. Patients who underwent ACDF and did not receive local corticosteroid injection at the time of ACDF were subsequently used to create a control cohort.
Study Outcomes and Statistical Analysis
The injection cohorts and control cohort were then queried for dysphagia within 90 days following ACDF using the following ICD-9 codes: 787. The demographics, comorbidities, and length of stay of the control cohort and study cohorts were recorded as provided by the database and compared. This included sex, age group (<70 years, 70-79 years, and !80 years), obesity, smoking status, and diabetes mellitus (DM). Statistical comparisons of postoperative dysphagia rates, infection and wound complication rates, length of stay, and demographic variables were completed using Pearson x 2 analysis. Odds ratios (ORs) were calculated with respective 95% confidence intervals (CIs). For all statistical comparisons, P < 0.05 was considered significant. SPSS version 21 for Macintosh (IBM, Armonk, NY) was used for all statistical comparisons.
RESULTS
About 245,754 unique patients who underwent ACDF were included in the study. This included 1770 patients who underwent short ACDF who received intraoperative local steroid and 198,230 patients who did not receive local steroid. In addition, there were 322 patients who underwent long ACDF who received intraoperative local steroid and 45,432 patients who did not. There were significantly more females in both the short and long ACDF groups who received intraoperative steroids and significantly more males in the respective control groups. Within the short ACDF group who received intraoperative steroid, there were significantly more patients in the less than 70 year old and 70 to 79 year old age groups than the control cohort.
There was also a significantly higher percentage of obese patients, smokers, and patients with DM in the short ACDF group who received intraoperative steroids. Similarly, there was a higher percentage of obese patients and patients with DM in the long ACDF group who received intraoperative steroids. Demographics for the study and control cohorts are presented in Tables 1 and 2 .
The incidence of dysphagia within 90 days following long ACDF was significantly lower in patients who received intraoperative application of local steroid than the control group (9.0% vs. 14.6%, OR 1.7, P ¼ 0.005); however, this difference was not observed in patients who underwent short ACDF (7.5% vs. 8.4%, OR 1.1, P ¼ 0.198). The mean difference in average length of stay was 1 day less for patients who received intraoperative local steroid for both long and short ACDF (P < 0.0001) ( Table 3) . Combined rates of infection and wound breakdown within 90 days of ACDF were not statistically different between patients who received local steroids and those who did not (1.7% in the steroid group vs. 1.6% in the no-steroid group, OR 0.9, 95% CI 0.7-1.3, P ¼ 0.717). The incidences of postoperative dysphagia and length of stay are presented in Table 3 with associated statistical comparisons.
DISCUSSION
The present study demonstrates that the use of local intraoperative steroid is associated with a significantly reduced rate of postoperative dysphagia after long ACDF and a reduced average length of stay for both long and short ACDF without any observed association with increased rates of postoperative infection or wound complications. Dysphagia following ACDF is associated with increased rates of aspiration pneumonia, feeding tube dependence, and tracheostomy, in addition to prolonged hospital length of stay and increased hospital related cost. 21 Furthermore, individuals with dysphagia report decreased quality of life. 22, 23 The available literature addressing dysphagia has largely focused on defining risk factors such as multilevel surgery, revision procedures, female gender, older age, and the involvement of the C4 to 6 levels. [11] [12] [13] When several risk factors are present, surgeons may opt to delay extubation, resulting in prolonged stay, increased hospital cost, and a delay in rehabilitation. More recently, several small, institutional studies have investigated the effects of perioperative systemic and local corticosteroids on decreasing prevertebral swelling and postoperative dysphagia. [16] [17] [18] [19] [20] These small, institutional studies investigating the effects of corticosteroids following anterior cervical spine surgery have produced conflicting results. [16] [17] [18] [19] 24 Given the significant morbidity of postoperative dysphagia, it is of high clinical significance to identify and evaluate measures that might help to reduce rates of this complication. Two recent studies have shown no difference in rates of dysphagia between patients who receive perioperative systemic steroids and those who do not. 16, 19 In a prospective trial, Pedram et al 16 infused 78 patients undergoing anterior cervical spine surgery with 1 mg/kg intravenous methylprednisone at the end of surgery, 12, and 24 hours postoperatively. In comparison to the control group, methylprednisone did not significantly reduce the incidence of subjective dysphagia, odynopagia, or impaired swallow function. In a similar study, Nam et al 19 performed a prospective randomized trial on the effect of postoperative systemic dexamethasone on prevertebral soft tissue swelling and subjective dysphagia. Sixty-two patients were randomly assigned to a high-dose steroid group, low-dose steroid group, or control group. All patients underwent preoperative, postoperative, and daily plain lateral radiographs for 5 days following the operation. The three groups showed no significant difference in prevertebral soft tissue density or subjective dysphagia scores. The group concluded that steroids are not effective in reducing postoperative prevertebral soft tissue swelling or subjective dysphagia.
In contrast, other groups have produced similar studies that have shown a significant reduction in postoperative dysphagia without additional complications in patients who received systemic steroid perioperatively. 17, 18 Song et al 17 prospectively administered intravenous methylprednisolone for 24 hours postoperatively to 20 patients undergoing multilevel ACDF compared with 20 patients undergoing the same procedure who did not receive steroid. The group reported a significant decrease in postoperative dysphagia, prevertebral swelling, and duration of hospital stay in the steroid group with no associated complications. The group concluded that systemic steroid administration is effective at decreasing prevertebral swelling and dysphagia in patients undergoing multilevel ACDF without any increased risk of complication. Jeyamohan et al 18 conducted a prospective, randomized, double-blinded, controlled study of 112 patients undergoing multilevel ACDF by a single surgeon over a 4-year period. Fifty-six patients were randomly assigned to receive intraoperative intravenous dexamethasone followed by 24 hours of postoperative steroid and compared with a control group of 56 patients who received saline. The group reported that perioperative steroids significantly improved swallowing function, airway edema, patient-reported dysphagia, and shortened length of stay.
Although systemic administration of steroids following ACDF has been relatively well studied, there has been only one study to date that has investigated the effectiveness of local steroids to reduce prevertebral soft tissue swelling and dysphagia after anterior cervical fusion. 20 Compared with intravenous steroids, local steroids have a decreased risk of systemic complications. 20 Lee et al 20 prospectively randomized 25 patients undergoing one or two-segment ACDF to receive a mixture of triamcinolone and morcellized collagen sponge applied to the retropharyngeal space before wound closure and compared them with a control group who did not receive steroid. Prevertebral soft tissue swelling was measured preoperatively, immediately postoperatively, and at 2 days, 4 days, 2 weeks, and at final follow-up. The group reported a significantly reduced prevertebral soft tissue swelling ratio in the steroid group immediately after surgery, 2 days, and 4 days in addition to a significant reduction in odynophagia at 2 weeks without any additional complications. The group concluded that the application of local steroids is a simple and effective method to decrease prevertebral soft tissue swelling and dysphagia following anterior cervical spine surgery.
The present study investigated the association of local steroid administration and postoperative dysphagia while also characterizing length of stay and infection rates. Aforementioned studies, many of which investigate systemic administration, have been limited by small cohorts that are at a high risk for confounding variables and insufficient clinical variation in the study population. Furthermore, several of the study groups contained high variability in the number of levels fused, which is a known risk factor for dysphagia. Moreover, given the low incidence of postoperative dysphagia and infection following anterior cervical spine surgery in the current literature, a large study cohort is necessary to sufficiently power an adequate analysis of these complications. In the present study, we evaluated a cohort that is more than 20 times larger than that previously reported in the current literature to demonstrate a significant reduction in postoperative dysphagia after long ACDF and reduced average length of stay for both long and short ACDF without any increase in infection or wound complication rates. These data are a valuable and significant contribution to the anterior cervical spine literature, and corroborate existing evidence on the effectiveness and safety of the application of local steroid at the time of ACDF.
The limitations are consistent with other studies that utilize large administrative databases such as PearlDiver. The power of our analysis relies on the quality of the data and the accuracy that these procedures are coded. As discussed throughout the manuscript, miscoding and noncoding by physicians are potential sources of error. A recent report that reflects Medicare discharges in a 12-month period ending December 31, 2006, reported the national coding error rate as 3.9%, and identified incorrect coding as one of the five root causes for errors. 25 Furthermore, the CPT-code for local administration of steroid at the time of surgery does not allow differentiation of the specific type of injection, application technique, or dosing. In addition, we are also unable to determine which levels were fused at the time of surgery, or if drains were placed at the time of surgery. We acknowledge that the use of drains might affect the local concentration of steroid used, and thus influence the efficacy of the steroid on postoperative dysphagia. By utilizing a database that draws from Medicare data, we attempt to accurately represent a large cross-section of the United States. Furthermore, the PearlDiver database only indexes a seven-year increment of data for this population. Thus, the few patients with post operative dysphagia following ACDF at the end of the indexed time period of the database may not be captured. Although the findings in our study represent 90-day outcomes to increase the likelihood that the complications were in fact related to the postoperative management of ACDF, some of the data may be related to other medical/surgical events and not the surgery. Similar to the other studies mentioned, late complications outside of the postoperative window are not captured in this study. Also, the data are reported in cohorts, preventing multivariate analysis and thus factors such as age, sex, and medical comorbidities cannot be controlled.
CONCLUSION
Current evidence is unclear on the relationship between perioperative steroid administration and postoperative dysphagia following ACDF. The present study demonstrates that the use of local intraoperative steroid is associated with a significantly reduced rate of postoperative dysphagia after long ACDF and a reduced average length of stay for both long and short ACDF without any observed association with increased rates of postoperative infection or wound complications.
Key Points
Current literature has largely focused on risk factors for postoperative dysphagia following ACDF, with less evidence on prevention and treatment. The PearlDiver administrative database was used to compare rates of postoperative dysphagia, length of stay, and infectious complications following long and short ACDF in patients who received steroids at the time of surgery and those who did not. The use of local intraoperative steroids was associated with a significantly reduced rate of postoperative dysphagia following long (three or more level) ACDF. Local intraoperative steroids are also associated with a reduced average length of stay for both long and short (one-two level) ACDF without any increased rates of postoperative infection or wound complications. The use of local intraoperative steroids may be an effective and safe practice to reduce postoperative dysphagia and length of stay following ACDF.
